administer rotavirus vaccine to infants with second-and/or third-trimester antenatal exposure to biologic DMARDs in utero (Table 6 For neonates/infants with second-and/or third-trimester antenatal exposure to TNFi, giving live attenuated rotavirus vaccine within the first 6 months of life is conditionally recommended. â€  For patients taking the equivalent of prednisone <20 mg/day or <2 mg/kg/day for patients weighing <10 kg or alternate-day glucocorticoid therapy (i.e., "low-level